News

We are excited to share that New York Blood Center Enterprises (NYBCe) has also released an announcement regarding our partnership.
By combining expertise from Japan and the U.S., we aim to establish a highly reproducible and scalable platform, making advanced cell therapy more accessible worldwide.
 
You can view NYBCe’s official release here:
New York Blood Center Enterprises and Human Life CORD Sign Letter of Intent to Expand Manufacturing Collaboration for Umbilical Cord -Derived Mesenchymal Stromal Cells